K143332

Substantially Equivalent

Fast Sphyg by Koven

Applicant: Koven Technology, Inc.
Product code: DXQ
Advisory panel: Cardiovascular
Date received: 2014-11-20
Decision date: 2015-04-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St Louis, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.